Du Pont Merck taps Dolighan

Du Pont Merck Pharmaceutical has named Richard Dolighan as president of its radiopharmaceuticals division in Billerica, MA. Dolighan most recently served as group vice president and general manager of North America for ICN Pharmaceuticals of Costa Mesa,

Du Pont Merck Pharmaceutical has named Richard Dolighan as president of its radiopharmaceuticals division in Billerica, MA. Dolighan most recently served as group vice president and general manager of North America for ICN Pharmaceuticals of Costa Mesa, CA. Dolighan replaces Kenneth Kasses as head of the Du Pont division.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.